These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23598435)

  • 1. Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma.
    Yu BF; Wu J; Zhang Y; Sung HW; Xie J; Li RK
    Cancer Gene Ther; 2013 May; 20(5):290-7. PubMed ID: 23598435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma.
    Liu C; Wen C; Wang X; Wei Y; Xu C; Mu X; Zhang L; Wang X; Tian J; Ma P; Meng F; Zhang Q; Zhao N; Yu B; Gong T; Guo R; Wang H; Xie J; Sun G; Li G; Zhang H; Qin Q; Xu J; Dong X; Wang L
    Exp Cell Res; 2019 Oct; 383(1):111496. PubMed ID: 31306654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
    Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y; Kaneko S; Nakamoto Y; Kagaya T; Mukaida N; Kobayashi K
    Cancer Gene Ther; 2001 Oct; 8(10):695-704. PubMed ID: 11687892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HSVtk/GCV system on hepatoma carcinoma cells: Construction of the plasmid pcDNA3.1‑pAFP-TK and targeted killing effect.
    Li YF; Yuan YY; Zhang YM; Zhao N; Zhang Q; Meng FX; Gao RP; Yu BF; Zhang YH; Guo R; Wang HL; Xie J; Xu J; Qin Q; Dong XS
    Mol Med Rep; 2017 Jul; 16(1):764-772. PubMed ID: 28560395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of plasmid vector pAFP-HSVtk-IRES2-EGFP and its effect on the cytotoxicity of ganciclovir to hepatocellular carcinoma.
    Lai Z; Qin Q; Yu B; Xie J; Gao R; Zhang T; Li C; Niu K; Xu J
    Chin Med J (Engl); 2014; 127(12):2337-41. PubMed ID: 24931253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connexin32‑mediated antitumor effects of suicide gene therapy against hepatocellular carcinoma: In vitro and in vivo anticancer activity.
    Wu L; Zhou WB; Shen F; Liu W; Wu HW; Zhou SJ; Li SW
    Mol Med Rep; 2016 Apr; 13(4):3213-9. PubMed ID: 26935255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.
    Castillo-Rodríguez RA; Arango-Rodríguez ML; Escobedo L; Hernandez-Baltazar D; Gompel A; Forgez P; Martínez-Fong D
    PLoS One; 2014; 9(5):e97151. PubMed ID: 24824754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation.
    Kawashita Y; Ohtsuru A; Kaneda Y; Nagayama Y; Kawazoe Y; Eguchi S; Kuroda H; Fujioka H; Ito M; Kanematsu T; Yamashita S
    Hum Gene Ther; 1999 Jun; 10(9):1509-19. PubMed ID: 10395376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53.
    Liu X; Wang S; Guo X; Wei F; Yin J; Zang Y; Li N; Chen D
    Oncotarget; 2016 Apr; 7(14):18896-905. PubMed ID: 26934443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
    Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
    BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.
    Park JH; Kim KI; Lee KC; Lee YJ; Lee TS; Chung WS; Lim SM; Kang JH
    Cancer Biother Radiopharm; 2015 Feb; 30(1):8-15. PubMed ID: 25545853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of HSVtk and connexin43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma.
    Ghoumari AM; Mouawad R; Zerrouqi A; Nizard C; Provost N; Khayat D; Naus CC; Soubrane C
    Gene Ther; 1998 Aug; 5(8):1114-21. PubMed ID: 10326035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene.
    Qu L; Wang Y; Gong L; Zhu J; Gong R; Si J
    Oncol Rep; 2013 Apr; 29(4):1435-40. PubMed ID: 23354806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged, NK cell-mediated antitumor effects of suicide gene therapy combined with monocyte chemoattractant protein-1 against hepatocellular carcinoma.
    Tsuchiyama T; Nakamoto Y; Sakai Y; Marukawa Y; Kitahara M; Mukaida N; Kaneko S
    J Immunol; 2007 Jan; 178(1):574-83. PubMed ID: 17182598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.
    Zerrouqi A; Rixe O; Ghoumari AM; Yarovoi SV; Mouawad R; Khayat D; Soubrane C
    Cancer Gene Ther; 1996; 3(6):385-92. PubMed ID: 8988841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and αVβ3 Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells.
    Li J; Zhou P; Li L; Zhang Y; Shao Y; Tang L; Tian S
    PLoS One; 2016; 11(7):e0158592. PubMed ID: 27391603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.